Live News

The Lancet Gastroenterology & Hepatology 柳叶刀胃肠病学和肝病学

[Articles] Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled pha

Immunology Division, The Walter and Eliza Hall Institute, Parkville, VIC, AustraliaDepartment of Medical Biology, Universi...

[Articles] Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled pha

Immunology Division, The Walter and Eliza Hall Institute, Parkville, VIC, AustraliaDepartment of Medical Biology, Universi...

[Articles] Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled pha

Immunology Division, The Walter and Eliza Hall Institute, Parkville, VIC, AustraliaDepartment of Medical Biology, Universi...

[Articles] Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled pha

Immunology Division, The Walter and Eliza Hall Institute, Parkville, VIC, AustraliaDepartment of Medical Biology, Universi...

[Articles] Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled pha

Immunology Division, The Walter and Eliza Hall Institute, Parkville, VIC, AustraliaDepartment of Medical Biology, Universi...

[Articles] Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled pha

Immunology Division, The Walter and Eliza Hall Institute, Parkville, VIC, AustraliaDepartment of Medical Biology, Universi...

[Articles] Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled pha

Immunology Division, The Walter and Eliza Hall Institute, Parkville, VIC, AustraliaDepartment of Medical Biology, Universi...

[Articles] Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled pha

Immunology Division, The Walter and Eliza Hall Institute, Parkville, VIC, AustraliaDepartment of Medical Biology, Universi...

[Comment] Bringing dietary therapy for eosinophilic oesophagitis under scientific scrutiny

In The Lancet Gastroenterology & Hepatology, Kara L Kliewer and colleagues report results from the first major multice...

Load More

Copyright © 2023 CN1699 Social. All rights reserved